(Q38432019)

English

Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study

scientific article published on June 2007

In more languages
default for all languages
No label defined

No description defined

Statements

Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit